For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...

“Late eating is associated with greater consumption of calories mostly from carbohydrates and fats and may lead to prolonged evening postprandial glucose excursions contributing to worse glucose ...

Shares of Sana Biotechnology Inc. (NASDAQ: SANA) were trading at $4.97, up $3.32, or 201%, on first results from an investigator-sponsored, first-in-human study transplanting UP-421, an allogeneic ...

We reviewed hundreds of skin care and makeup products to bring you the best of Shop TODAY's 2024 Beauty Awards. From skin ...

Stock futures dipped on Wednesday as renewed concerns over U.S. inflation weighed on sentiment. Investors awaited the release ...

Sana Biotechnology's first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes ...

Sana Biotechnology’s innovative approach to treating type 1 diabetes centers around its HIP-modified pancreatic islet cell transplant. In the context of type 1 diabetes, the body’s immune system ...

Sana Biotechnology (SANA) announced initial results from an investigator-sponsored, first-in-human study transplanting UP421, an allogeneic ...

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight reduction and 43% increase in lean muscle mass compared ...

A study of 116 clinical trials found that to achieve significant weight loss, people need to commit to at least 150 minutes ...

Lucknow: Contrary to the popular belief that black coffee and green team contract blood sugar and improve insulin sensitivity ...